
|Videos|January 24, 2019
Steps to Successful Management of Immunotherapy Toxicities
Author(s)Ezra Cohen, MD, FRCPSC, FASCO
Ezra Cohen, MD, FRCPSC, FASCO, discusses the most important parts of successfully managing toxicities related to treatment with immunotherapy.
Advertisement
Ezra Cohen, MD, FRCPSC, FASCO, professor of medicine, associate director, translational science, Moores Cancer Center, University of California San Diego, discusses the most important parts of successfully managing toxicities related to treatment with immunotherapy.
Cohen says first, patients need to be educated on the toxicities that could present themselves and should notify their physician immediately should any symptoms appear. Cohen also says that the earlier the symptoms are seen, the easier it is to manage these toxicities and avoid them from escalating to life-threatening situations.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts NDA for Daraxonrasib in Metastatic Pancreatic Cancer
2
Advanced Renal Cell Carcinoma: Tailoring Second-Line Therapy After Prior Immunotherapy
3
Teclistamab/Talquetamab Reduces Risk of Progression by 89% in R/R Multiple Myeloma
4
Updated HARMONi Analysis Shows Consistent OS Benefit With Ivonescimab in EGFRm Lung Cancer
5































